Lhasa Limited shared knowledge shared progress
  • Highlighted Item:
  • Publisher:
    U.S. Food and Drug Administration
  • Publication Date:
    Mar 2016
  • Reference:
  • DOI:
  • PMID:
  • Publication Type:
  • Related Products:
  • Scientific Area:
  • Endpoint:
  • Industry Type:
  • Related event:

Implementation of ICH M7 Recommended (Q)SAR Analyses

pdf fileKruhlak NL; Stavitskaya L;

Presented by Naomi Kruhlak and Lidiya Stavitskaya at the the 2016 Society of Toxicology Annual Meeting.

This presentation explores (Q)SAR modeling and its use in impurity assessment. Delivered by members of the FDA, the session looks at why (Q)SAR is used in modeling with specific reference to its use in ICHM7.



© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.